These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1597205)

  • 21. Impact of quinupristin/dalfopristin (RP59500) on the faecal microflora in healthy volunteers.
    Scanvic-Hameg A; Chachaty E; Rey J; Pousson C; Ozoux ML; Brunel E; Andremont A
    J Antimicrob Chemother; 2002 Jan; 49(1):135-9. PubMed ID: 11751777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial-drug resistance.
    Gold HS; Moellering RC
    N Engl J Med; 1996 Nov; 335(19):1445-53. PubMed ID: 8875923
    [No Abstract]   [Full Text] [Related]  

  • 23. Recovery of pefloxacin in saliva and feces and its action on oral and fecal floras of healthy volunteers.
    Janin N; Meugnier H; Desnottes JF; Woehrle R; Fleurette J
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1665-8. PubMed ID: 3481248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects on oral and intestinal microfloras of norfloxacin and pefloxacin for selective decontamination in bone marrow transplant patients.
    Giuliano M; Pantosti A; Gentile G; Venditti M; Arcese W; Martino P
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1709-13. PubMed ID: 2686547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibiotic resistance among indicator bacteria isolated from healthy pigs in New Zealand.
    Nulsen MF; Mor MB; Lawton DE
    N Z Vet J; 2008 Feb; 56(1):29-35. PubMed ID: 18322557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
    Croize J; Le Noc P; Bryskier A; Robert J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pefloxacin and immunity: cellular uptake, potentiation of macrophage phagocytosis and intracellular bioactivity for Klebsiella pneumoniae.
    Cuffini AM; Tullio V; Fazari S; Allocco A; Carlone NA
    Int J Tissue React; 1992; 14(3):131-9. PubMed ID: 1446977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-vitro selection of bacteria resistant to the 4-quinolone agents.
    Limb DI; Dabbs DJ; Spencer RC
    J Antimicrob Chemother; 1987 Jan; 19(1):65-71. PubMed ID: 3470281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Isolation of a Staphylococcus aureus strain resistant to pefloxacin after treatment with pefloxacin and gentamycin].
    Chomarat M; Gerbaud G; Vital-Durand D
    Pathol Biol (Paris); 1990 May; 38(5):474-6. PubMed ID: 2164184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibacterial activity of pefloxacin in the urine during the 7 days following a single 800 mg oral dose].
    Guibert J; Kitzis MD; Brumpt I; Acar JF
    Pathol Biol (Paris); 1989 May; 37(5):406-10. PubMed ID: 2506514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial resistance in India and the United States.
    Peter JB
    Clin Infect Dis; 1996 Dec; 23(6):1315-6. PubMed ID: 8953081
    [No Abstract]   [Full Text] [Related]  

  • 32. [Activity of 5 fluoroquinolones on hospital Gram-negative bacilli with different sensitivities to pefloxacin].
    Aubert G; Puech C; Lucht F; Loboguerrero M; Denis M; Dorche G
    Pathol Biol (Paris); 1989 Oct; 37(8):881-7. PubMed ID: 2515519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of amoxycillin, erythromycin and roxithromycin on colonization resistance and on appearance of secondary colonization in healthy volunteers.
    Vollaard EJ; Clasener HA; van Griethuysen AJ; Janssen AJ; Sanders-Reijmers AJ
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():131-8. PubMed ID: 3429382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pefloxacin efficacy in gram-negative bacillary meningitis.
    Segev S; Rosen N; Joseph G; Elran HA; Rubinstein E
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():187-92. PubMed ID: 2258348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies.
    D'Antonio D; Piccolomini R; Iacone A; Fioritoni G; Parruti G; Betti S; Quaglietta AM; Accorsi P; Dell'Isola M; Favalli C
    J Antimicrob Chemother; 1994 Apr; 33(4):837-44. PubMed ID: 8056702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cefepime use in a pediatric intensive care unit reduces colonization with resistant bacilli.
    Toltzis P; Dul M; O'Riordan MA; Salvator A; Rosolowski B; Toltzis H; Blumer JL
    Pediatr Infect Dis J; 2003 Feb; 22(2):109-14. PubMed ID: 12586972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Course of the resistance of Staphylococcus aureus to pefloxacin. A study based on 782 strains isolated in 1985 and 1986].
    Jean-Pierre H; Boyer G; Jean A; Darbas H
    Pathol Biol (Paris); 1988 Oct; 36(8):956-8. PubMed ID: 3059287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Report: pharmacokinetic and drug interaction studies of pefloxacin with paracetamol (NNAID) in healthy volunteers in Pakistan.
    Gauhar S; Ali SA; Naqvi SB; Shoaib MH
    Pak J Pharm Sci; 2014 Mar; 27(2):389-95. PubMed ID: 24577931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative in vitro susceptibility of clinical bacterial isolates to pefloxacin and 14 antibiotics].
    Dolna I; Ruczkowska J; Chomontowicz M
    Przegl Lek; 1992; 49(7):213-5. PubMed ID: 1297147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colonization of skilled-care facility residents with antimicrobial-resistant pathogens.
    Trick WE; Weinstein RA; DeMarais PL; Kuehnert MJ; Tomaska W; Nathan C; Rice TW; McAllister SK; Carson LA; Jarvis WR
    J Am Geriatr Soc; 2001 Mar; 49(3):270-6. PubMed ID: 11300237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.